Novo Nordisk
NVO
NVO
473 hedge funds and large institutions have $8.87B invested in Novo Nordisk in 2014 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 170 increasing their positions, 165 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 165
7% less funds holding in top 10
Funds holding in top 10: 28 → 26 (-2)
70% less call options, than puts
Call options by funds: $3.07M | Put options by funds: $10.2M
Holders
473
Holding in Top 10
26
Calls
$3.07M
Puts
$10.2M
Top Buyers
| 1 | +$73.8M | |
| 2 | +$51.3M | |
| 3 | +$40.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.4M |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$18.9M |
Top Sellers
| 1 | -$376M | |
| 2 | -$59.2M | |
| 3 | -$21M | |
| 4 |
CCM
Chautauqua Capital Management
Boulder,
Colorado
|
-$20.9M |
| 5 |
RFS
Rockefeller Financial Services
New York
|
-$13.6M |